Quantcast

Latest pulmonary fibrosis Stories

2011-03-17 14:03:00

Guidelines Update 11-Year-Old Consensus Statement for Deadly Lung Disease CULVER CITY, Calif., March 16, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) applauds the joint statement issued by the American Thoracic Society for the first evidence-based clinical guidelines for the treatment of idiopathic pulmonary fibrosis (IPF). The guidelines represent progress in understanding of the disease and a milestone for patients. The devastating and deadly disease also...

2011-02-23 10:00:00

CPF and PFF Commit to ATS to Fund Grants CULVER CITY, Calif., Feb. 23, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF), the Pulmonary Fibrosis Foundation (PFF), and the American Thoracic Society (ATS), the world's leading professional organization for pulmonary, critical care and sleep medicine, today announced that the CPF and PFF will again partner with the ATS to fund Pulmonary Fibrosis (PF) research. "The CPF is dedicated to this important partnership with...

2011-02-10 19:50:00

Novel Therapeutic Approach Regulates All Fibrotic Pathologies Driven by TGF-beta1, a Major Mediator of Idiopathic Pulmonary Fibrosis (IPF) Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P." The research...

2010-12-21 15:59:00

Esbriet (Pirfenidone) Passes Hurdle, Way Clear for EU Approval CULVER CITY, Calif., Dec. 21, 2010 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced to more than 128,000 patients news that the first drug for the treatment of the deadly lung disease Pulmonary Fibrosis (PF) has passed a major hurdle in the European regulatory process and is likely to be approved in all 27 member countries of the European Union (EU). The drug, Espriet (Pirfenidone), has received...

2010-12-20 10:00:00

Pulmonary Fibrosis Efforts Grow in 2010 CULVER CITY, Calif., Dec. 20, 2010 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) achieved milestones in 2010 in advocacy, research support and awareness of Pulmonary Fibrosis (PF). PF is a fatal disease that has no known cause, no FDA-approved treatment, and no cure. The CPF increased national awareness efforts in 2010, via non-traditional as well as mainstream media. Stories of PF, through the personal accounts of patients...

2010-12-08 15:40:00

Pulmonary Fibrosis Claims as Many Lives Each Year as Breast Cancer, Yet Virtually Unknown PEORIA, Ariz., Dec. 8, 2010 /PRNewswire-USNewswire/ -- Elliot Walsey is on a mission to save others who suffer from the disease that will likely kill him. He was diagnosed September 2006 with pulmonary fibrosis (PF), a deadly lung disease that has no FDA approved treatment and no cure. The disease, characterized by uncontrolled and lethal scarring, is virtually unknown to the general population,...

2010-10-04 11:36:00

CULVER CITY, Calif., Oct. 4 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) has announced its annual awards honoring three critical areas of leadership that impact the work of the Pulmonary Fibrosis (PF) community. The recipients, Bob and Sandy O'Rourke, Congressman Brian Baird, and Dr. Naftali Kaminski, are champions for the always-fatal disease by trying to create change, offering support, and giving hope. "The Coalition is proud to honor individuals who have...

2010-09-30 05:30:00

Volunteers, Families Unite in IL, IN, NY, and PA to Raise Money and Awareness of Pulmonary Fibrosis in Their Communities CHICAGO, Sept. 30 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced its October schedule of fundraising events as part of its ongoing national campaign to raise funds for pulmonary fibrosis (PF) research, while supporting the PFF's patient education and advocacy efforts throughout the country. The PFF has seen continued expansion of its...

2010-09-22 16:29:00

CULVER CITY, Calif., Sept. 22 /PRNewswire-USNewswire/ -- During the 8th annual National Pulmonary Fibrosis (PF) Awareness Week, Sept. 11 to 18, the Coalition for Pulmonary Fibrosis (CPF) met with over 45 legislators, both Representatives and Senators, and as of this date there are 139 House co-sponsors for the Pulmonary Fibrosis Research Enhancement Act (PFREA) to fund research on this deadly disease. Pulmonary Fibrosis patients, their families and supporters targeted this year's visits to...

2010-09-07 09:36:00

CULVER CITY, Calif., Sept. 7 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) kicks off the 8th annual National Pulmonary Fibrosis (PF) Awareness Week Sept. 11 to 18. The primary goals of this year's activity are to ensure passage of the Pulmonary Fibrosis Research Enhancement Act (PFREA), in the Senate and the House, and to raise awareness of Pulmonary Fibrosis issues in communities nationwide. Specifically, the CPF is asking its national membership and others...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.